169 related articles for article (PubMed ID: 23093910)
1. Polypodium leucotomos Extract use to prevent and reduce the risk of infectious diseases in high performance athletes.
Solivellas BM; Martín TC
Infect Drug Resist; 2012; 5():149-53. PubMed ID: 23093910
[TBL] [Abstract][Full Text] [Related]
2. Polypodium leucotomos extract in atopic dermatitis: a randomized, double-blind, placebo-controlled, multicenter trial.
Ramírez-Bosca A; Zapater P; Betlloch I; Albero F; Martínez A; Díaz-Alperi J; Horga JF;
Actas Dermosifiliogr; 2012 Sep; 103(7):599-607. PubMed ID: 22560125
[TBL] [Abstract][Full Text] [Related]
3. Effect of Anapsos (Polypodium leucotomos extract) on in vitro production of cytokines.
Sempere JM; Rodrigo C; Campos A; Villalba JF; Diaz J
Br J Clin Pharmacol; 1997 Jan; 43(1):85-9. PubMed ID: 9056057
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory effect of Polypodium leucotomos (Anapsos) in child palatine tonsil model.
Sánchez-Rodríguez C; Peraza Cruces KR; Rodrigáñez Riesco L; García-Vela JA; Sanz-Fernández R
Int J Pediatr Otorhinolaryngol; 2018 Apr; 107():56-61. PubMed ID: 29501312
[TBL] [Abstract][Full Text] [Related]
5. Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.
Nestor M; Bucay V; Callender V; Cohen JL; Sadick N; Waldorf H
J Clin Aesthet Dermatol; 2014 Mar; 7(3):13-7. PubMed ID: 24688621
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects.
Nestor MS; Berman B; Swenson N
J Clin Aesthet Dermatol; 2015 Feb; 8(2):19-23. PubMed ID: 25741399
[TBL] [Abstract][Full Text] [Related]
7. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study.
Middelkamp-Hup MA; Bos JD; Rius-Diaz F; Gonzalez S; Westerhof W
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):942-50. PubMed ID: 17659004
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of a fixed Polypodium leucotomos/Pomegranate combination versus Polypodium leucotomos alone on skin biophysical parameters.
Emanuele E; Bertona M; Biagi M
Neuro Endocrinol Lett; 2017 Feb; 38(1):38-42. PubMed ID: 28456146
[TBL] [Abstract][Full Text] [Related]
9. Polypodium leucotomos: a potential new photoprotective agent.
Bhatia N
Am J Clin Dermatol; 2015 Apr; 16(2):73-9. PubMed ID: 25666116
[TBL] [Abstract][Full Text] [Related]
10.
Del Rosso JQ
J Clin Aesthet Dermatol; 2019 Aug; 12(8):45-46. PubMed ID: 31531171
[No Abstract] [Full Text] [Related]
11. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
[TBL] [Abstract][Full Text] [Related]
12. Short-term administration of Polypodium leucotomos extract does not inhibit CYP3A4-mediated metabolism of midazolam in healthy subjects: an open-label, two-period, fixed-sequence study.
Shinya K; Nishimura Y; Ryu K; Sambe T; Fujishiro M; Nakauchi A; Kashiwabuchi Y; Iwase M; Chokki H; Kurata N; Matsuyama T; Kiuchi Y
Int J Dermatol; 2023 May; 62(5):694-699. PubMed ID: 35751767
[TBL] [Abstract][Full Text] [Related]
13. Role of oral Polypodium leucotomos extract in dermatologic diseases: a review of the literature.
Choudhry SZ; Bhatia N; Ceilley R; Hougeir F; Lieberman R; Hamzavi I; Lim HW
J Drugs Dermatol; 2014 Feb; 13(2):148-53. PubMed ID: 24509964
[TBL] [Abstract][Full Text] [Related]
14. Polypodium leucotomos extract: a status report on clinical efficacy and safety.
Winkelmann RR; Del Rosso J; Rigel DS
J Drugs Dermatol; 2015 Mar; 14(3):254-61. PubMed ID: 25738847
[TBL] [Abstract][Full Text] [Related]
15. Vandetanib-induced Phototoxic Drug Eruption Treated with
Korman AM; Reynolds KA; Nabhan F; Konda B; Shah MH; Kaffenberger BH
J Clin Aesthet Dermatol; 2019 Oct; 12(10):35-38. PubMed ID: 32038747
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effectiveness and safety of combined oral and topical photoprotection with a standardized extract of Polypodium leucotomos (Fernblock®) in a Moroccan population with xeroderma pigmentosum.
El Mansouri M; Essaddouki S; Mouradi M; Oukerroum A; El Fatoiki FZ; Truchuelo MT; Vitale MA; González S; Chiheb S
Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):607-612. PubMed ID: 37584519
[TBL] [Abstract][Full Text] [Related]
17. Attenuation of actinic prurigo eruptions with Polypodium leucotomos supplementation.
Stump M; Dhinsa H; Powers J; Stone M
Pediatr Dermatol; 2022 Jan; 39(1):145-146. PubMed ID: 34888940
[TBL] [Abstract][Full Text] [Related]
18. Beneficial regulation of matrixmetalloproteinases and their inhibitors, fibrillar collagens and transforming growth factor-beta by Polypodium leucotomos, directly or in dermal fibroblasts, ultraviolet radiated fibroblasts, and melanoma cells.
Philips N; Conte J; Chen YJ; Natrajan P; Taw M; Keller T; Givant J; Tuason M; Dulaj L; Leonardi D; Gonzalez S
Arch Dermatol Res; 2009 Aug; 301(7):487-95. PubMed ID: 19373483
[TBL] [Abstract][Full Text] [Related]
19. The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study.
Kohli I; Shafi R; Isedeh P; Griffith JL; Al-Jamal MS; Silpa-Archa N; Jackson B; Athar M; Kollias N; Elmets CA; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Jul; 77(1):33-41.e1. PubMed ID: 28341348
[TBL] [Abstract][Full Text] [Related]
20. The potential effect of Polypodium leucotomos extract on ultraviolet- and visible light-induced photoaging.
Pourang A; Dourra M; Ezekwe N; Kohli I; Hamzavi I; Lim HW
Photochem Photobiol Sci; 2021 Sep; 20(9):1229-1238. PubMed ID: 34449075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
